T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$1.6B |
| 2 |
Verizon
VZ
|
+$1.3B |
| 3 |
US Bancorp
USB
|
+$1.26B |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$1.26B |
| 5 |
Lam Research
LRCX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$6.33B |
| 2 |
Tesla
TSLA
|
+$5.64B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$4.91B |
| 4 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$3.44B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.7% |
| 2 | Healthcare | 19.64% |
| 3 | Financials | 12.71% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KDNY
1951
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $719K | ﹤0.01% |
27,461
+1,035
| +4% | +$22.9K |
|
1952
Pediatrix Medical
MD
$2.15B
| $716K | ﹤0.01% |
48,187
-10,922
| -18% | -$178K |
|
|
BHR
1953
Braemar Hotels & Resorts
BHR
$139M
| $715K | ﹤0.01% |
173,890
+127,409
| +274% | +$523K |
|
|
SPTN
1954
DELISTED
SpartanNash
SPTN
| $712K | ﹤0.01% |
23,561
+3,162
| +16% | +$103K |
|
1955
CarGurus
CARG
$3.29B
| $710K | ﹤0.01% |
50,658
+1,454
| +3% | +$19.9K |
|
|
DVAX
1956
DELISTED
Dynavax Technologies
DVAX
| $710K | ﹤0.01% |
66,744
-6,494
| -9% | -$75.5K |
|
1957
Fastly Inc
FSLY
$4.78B
| $710K | ﹤0.01% |
86,735
+23,360
| +37% | +$205K |
|
1958
Abercrombie & Fitch
ANF
$4.99B
| $709K | ﹤0.01% |
30,950
+9,001
| +41% | +$177K |
|
1959
TFI International
TFII
$12B
| $708K | ﹤0.01% |
+7,060
| New | +$705K |
|
|
MRSN
1960
DELISTED
Mersana Therapeutics
MRSN
| $707K | ﹤0.01% |
4,821
+339
| +8% | +$57.3K |
|
1961
Wabash National
WNC
$507M
| $707K | ﹤0.01% |
31,275
-2,497
| -7% | -$54.2K |
|
|
LTC
1962
LTC Properties
LTC
$2.1B
| $706K | ﹤0.01% |
19,878
+696
| +4% | +$26.5K |
|
1963
AdaptHealth
AHCO
$770M
| $705K | ﹤0.01% |
36,668
-2,589
| -7% | -$54.7K |
|
1964
Sterling Infrastructure
STRL
$16.8B
| $700K | ﹤0.01% |
21,332
-2,065
| -9% | -$60.7K |
|
1965
Enviri
NVRI
$583M
| $699K | ﹤0.01% |
111,104
+1,165
| +1% | +$6.94K |
|
1966
Northwest Bancshares
NWBI
$2.31B
| $698K | ﹤0.01% |
49,894
-15,899
| -24% | -$229K |
|
1967
Dave & Buster's
PLAY
$361M
| $698K | ﹤0.01% |
19,690
-156
| -0.8% | -$5.64K |
|
|
NOVA
1968
DELISTED
Sunnova Energy
NOVA
| $696K | ﹤0.01% |
38,661
-5,494
| -12% | -$111K |
|
|
DENN
1969
DELISTED
Denny's
DENN
| $695K | ﹤0.01% |
75,513
+8,115
| +12% | +$87.9K |
|
1970
Ezcorp Inc
EZPW
$1.78B
| $694K | ﹤0.01% |
85,193
-25,381
| -23% | -$226K |
|
1971
Horizon Bancorp
HBNC
$1.05B
| $692K | ﹤0.01% |
45,894
+15,223
| +50% | +$251K |
|
1972
Construction Partners
ROAD
$6.9B
| $692K | ﹤0.01% |
25,918
-2,028
| -7% | -$58.1K |
|
1973
Telephone and Data Systems
TDS
$3.82B
| $690K | ﹤0.01% |
65,749
+7,252
| +12% | +$89.7K |
|
|
CLDT
1974
Chatham Lodging
CLDT
$590M
| $689K | ﹤0.01% |
56,138
+800
| +1% | +$9.87K |
|
1975
Sunstone Hotel Investors
SHO
$2.01B
| $688K | ﹤0.01% |
71,256
-29,261
| -29% | -$302K |
|
Similar funds
T. Rowe Price Associates's Q4 2022 Portfolio in Review
As of Q4 2022, T. Rowe Price Associates held 3,066 positions worth $622B, up 1.8% from $610B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
T. Rowe Price Associates's Q4 2022 filing shows 113 new, 1,569 increased, 1,081 reduced and 107 closed positions. Its largest new stake was GE HealthCare: 6,360,001 shares worth $371M. The largest sale was Amazon, an estimated $6.33B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2022 buy was GE HealthCare: 6,360,001 shares worth $371M.
- T. Rowe Price Associates added most to JPMorgan Chase in Q4 2022, an estimated $1.6B increase.
- T. Rowe Price Associates's biggest Q4 2022 reduction was Amazon, cutting an estimated $6.33B.
- T. Rowe Price Associates fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $3.44B.
- T. Rowe Price Associates's ten largest holdings make up 27% of its $622B portfolio in Q4 2022.
- T. Rowe Price Associates opened 113 new positions and closed 107 in Q4 2022.
- T. Rowe Price Associates's portfolio value rose 1.8% quarter-over-quarter to $622B.
Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.